Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06337708 · ClinicalTrials.gov registry record · Phase 2
Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women
A Phase 2 study of Diabetes Mellitus and Physical Activity, sponsored by Arizona State University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT06337708 is a Phase 2 study of Diabetes Mellitus and Physical Activity that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 240 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06337708, a Phase 2 study of Diabetes Mellitus and Physical Activity, is actively recruiting participants, sponsored by Arizona State University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
Conditions Studied
Interventions
- BEHAVIORAL Fitbit
- BEHAVIORAL Smart Walk
Study Locations (1)
Arizona
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2028-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06337708
The ClinicalTrials.gov registry entry for NCT06337708 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (87% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Fitbit is the first listed.
NCT06337708 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06337708 about?
NCT06337708 is a clinical study titled "Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women". The purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
What is the current status of trial NCT06337708?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2024-04-08. Estimated completion is 2028-03-31.
What conditions does trial NCT06337708 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Physical Activity, Heart Diseases, Physical Inactivity, Exercise.
What interventions are being tested in trial NCT06337708?
The interventions under investigation include: Fitbit (BEHAVIORAL), Smart Walk (BEHAVIORAL).
Who is sponsoring clinical trial NCT06337708?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06337708 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
RECRUITING · Phase 2
-
Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia
RECRUITING · Phase 2
-
Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus
RECRUITING · Phase 2
-
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
RECRUITING · Phase 2
-
Sleep, Diabetic Retinopathy and Melatonin
RECRUITING · Phase 2
-
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.